Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

24 August 2024: Articles  Japan

Bloodstream Infection in a Lymphoma Patient Undergoing Chemotherapy: A Case Study and Implications for Probiotic Use

Unusual clinical course, Diagnostic / therapeutic accidents, Unexpected drug reaction

Osamu Imataki ORCID logo1ABCDEFG*, Makiko Uemura ORCID logo1ABCDEFG

DOI: 10.12659/AJCR.944687

Am J Case Rep 2024; 25:e944687

0 Comments

Abstract

0:00

BACKGROUND: Fermenting bacilli producing lactic acid, including Bifidobacterium spp., are supposed to have low pathogenicity and no virulence for humans. Probiotics consisting of those fermenting bacilli can prevent and treat symptomatic gastrointestinal conditions, such as diarrhea. We use probiotics even in cancer patients, those who are immunocompromised, because a preferable effect to the intestinal commensal microbiome has been shown in a recent report. Some case reports warn of a rare risk of bloodstream infection caused by probiotics. However, complete prohibition of probiotic use in cancer patients abandons the benefits.

CASE REPORT: A 75-year-old Japanese woman with malignant lymphoma was treated with immune-chemotherapy regimen consisting of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). The patient had onset of febrile neutropenia during chemotherapy and had Bifidobacterium breve bloodstream infection on day 8 after the eighth R-CHOP treatment. She had usually eaten commercial yogurt every morning. This yogurt was produced from only Lactobacillus bulgaricus and Streptococcus thermophilus. It did not contain Bifidobacterium breve. The bloodstream infection in this case looked like it derived from her food; however, it was not associated with her habitual foods. The patient was treated with meropenem for 8 days and experienced complete remission of the bloodstream infection.

CONCLUSIONS: We speculate that fermenting bacilli can also be a source of bloodstream infection, not necessarily associated with probiotic strains, in cancer patients treated with chemotherapy. Additionally, we recommend that probiotics can alleviate alimentary tract symptoms in immunocompromised patients.

Keywords: Bacteremia, Bifidobacterium breve, Immunocompromised Host, Lymphoma, Probiotics

Introduction

Probiotics are fermented organisms producing lactic acid, which promotes a favorable effect on the intestinal immune system. Clinical trials have demonstrated optimal outcomes with probiotics in cancer patients after chemotherapy [1]. While rare infectious complications associated with probiotics are infrequently reported, a pessimistic study suggests avoiding probiotics in immunocompromised hosts to prevent low-frequency bloodstream infections (BSI) caused by low pathogenic virulence pathogens. However, probiotic-induced BSI is rare, and BSI from other low-virulence organisms occurs in immunocom-promised patients, even without probiotics [2]. Despite these considerations, the overall positive impact of probiotics in patients with cancer remains significant.

Bifidobacterium spp., including Bifidobacterium breve, ferment intestinal microorganisms that comprise the human microbiome. Bifidobacterium spp. are nonvirulent anaerobic gram-positive rods that live in the gut of healthy people. When these bacteria establish a pathogenic infection in humans, the host is immunocompromised, and the infection is opportunistic [2]. According to many case reports, Bifidobacterium bacteremia is a rare opportunistic infection caused by underlying diseases, all of which are severe or chronic gastrointestinal diseases [3], with the occasional immune-compromised condition [4]. In our clinical oncology experience, BSIs caused by commensal bacteria are opportunistic in immunocompromised hosts, such as patients undergoing chemotherapy [3].

Case Report

A 75-year-old Japanese woman with malignant lymphoma (diffuse large B-cell lymphoma) was treated with the rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) regimen. A large mass was found on her left cervical lymph node. Malignant lymphoma had a poor risk status in the revised international prognostic index (IPI) and a high intermediate risk in the NCCN-IPI. She achieved complete remission after 8 courses of R-CHOP. The dosage of the CHOP regimen was adjusted with a 50% reduction in the first cycle, followed by a 20% reduction in the second cycle, and full dose administration after the third cycle. The dose modification was due to the patient’s general condition. At the last course of chemotherapy, she developed febrile neutropenia (white blood cell count of 1900/µL and neutrophil count of 87/ µL) with mild diarrhea on day 8 after the eighth R-CHOP, despite of the use of pegfilgrastim 3.6 mg. This febrile episode marked the patient’s initial occurrence of febrile neutropenia. She was admitted to the hospital for treatment of febrile neutropenia. Blood culture at the onset of febrile neutropenia revealed bacteremia caused by B. breve. BSI caused by B. breve was diagnosed, and she was given meropenem 1.0 g/day for 8 days (until day 16) as an empirical treatment. However, the drug sensitivity indicated that meropenem was resistant to the detected organism, B. breve. The drug sensitivity results for isolated B. breve are shown in Table 1. The patient did not use anti-acid medication. She was not given probiotics; however, she preferred to eat commercial yogurt (Meiji Bulgaria Yogurt, Meiji Corporation, Ltd., Tokyo) every morning until admission. This yogurt is produced from only Lactobacillus bulgaricus and Streptococcus thermophilus. It does not contain B. breve (according to official information). We concluded that she was not infected by food yogurt. We speculated that isolated B. breve was derived from the patient’s commensal bacterial flora. Her neutropenia had completely recovered, reaching 2148/mL on day 12. Her febrile status was reduced to the normal range on day 13. Her infectious condition fully resolved following the recovery from neutropenia. However, despite an 8-day course of meropenem, the effectiveness of antimicrobial treatment remained uncertain. This uncertainty stemmed from the in vitro drug sensitivity test, which indicated resistance of isolated B. breve to meropenem (Table 1).

Discussion

In our field, hematological malignancies, including malignant lymphoma, require several months of constitutive chemoimmunotherapy with the R-CHOP regimen. In these cases, probiotics, such as fermenting bacilli that produce lactic acid, can sometimes be a suspicious preparation drug, causing probiotic-associated BSI [6]. In some cases, probiotics have been used to identify genetic isolates derived from blood cultures and organisms [7]. In other cases, clinical isolates from blood had identically different phenotypes from probiotic strains, using molecular methods [8]. Thus, the consistency or association between probiotic treatment and BSI is not well established. In another view, a neutropenic diet devoid of raw food was not linked to an increased risk of infections and mortality [9,10]. These fermenting bacteria are found in the human gastrointestinal tract. Although microorganisms in the gastrointestinal tract are less pathogenic than bacteria, almost all of them are antimicrobial-resistant. We believe that even if 2 isolates of BSI and probiotics are identified as the same species, this does not always imply that the BSI originated from probiotics. In the present case, B. breve BSI was not caused by probiotics contained in the patients’ diet.

As demonstrated in this case, probiotics, including food and pharmaceutical lactic acid bacteria preparations, do not always cause lactate-producing bacteria translocation in the alimentary tract. In our case, one of the commensal nonvirulent bacteria, B. breve, caused BSI, a potentially severe infection. We considered that the isolation of B. breve in this case was true bacterial BSI. In our speculation, other causative agents of this serious infection derived from commensal bacteria should be recognized as an opportunistic infection other than B. breve. Therefore, it is necessary to support cases in which rare indigenous bacteria with little risk cause febrile neutropenia in a patient with cancer, even without probiotics. Some clinical evidence suggests that probiotics can help reduce clinical symptoms and infections [11,12]. Furthermore, synbiotics can improve intestinal barrier function [13]. Even in recipients of hematopoietic stem cell transplantation, the use of probiotic formations did not affect the incidence of BSI caused by pro-biotic organisms [14].

Conclusions

We observed that fermenting bacilli, including Bifidobacterium spp., can also be a source of BSI, not necessarily associated with probiotic strains, in cancer patients undergoing chemo-therapy. We advocate that probiotics should not always be prohibited in immunocompromised patients.

References:

1.. Noor S, Ali S, Riaz S, Chemopreventive role of probiotics against cancer: A comprehensive mechanistic review: Mol Biol Rep, 2023; 50; 799-814

2.. Kreitmann L, Helms J, Martin-Loeches I, ICU-acquired infections in immunocompromised patients: Intensive Care Med, 2024; 50; 332-49

3.. Esaiassen E, Hjerde E, Cavanagh JP, ; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium Bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity: J Clin Microbiol, 2017; 55; 2234-48

4.. Bertelli C, Pillonel T, Torregrossa A: Clin Infect Dis, 2015; 60; 924-27

5.. Weber E, Reynaud Q, Suy F: Clin Infect Dis, 2015; 61; 482-84

6.. Salminen MK, Rautelin H, Tynkkynen S: Clin Infect Dis, 2004; 38; 62-69

7.. Rubin IMC, Stevnsborg L, Mollerup S: Infect Prev Pract, 2022; 4; 100200

8.. Ouwehand AC, Saxelin M, Salminen S: Clin Infect Dis, 2004; 39; 1858-60

9.. Moody K, Charlson ME, Finlay J, The neutropenic diet: What’s the evidence?: J Pediatr Hematol Oncol, 2002; 24; 717-21

10.. Sonbol MB, Jain T, Firwana B, Neutropenic diets to prevent cancer infections: Updated systematic review and meta-analysis: BMJ Support Palliat Care, 2019; 9(4); 425-33

11.. Shimizu K, Ogura H, Kabata D, Association of prophylactic synbiotics with reduction in diarrhea and pneumonia in mechanically ventilated critically ill patients: A propensity score analysis: J Infect Chemother, 2018; 24; 795-801

12.. Shimizu K, Yamada T, Ogura H, Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: A randomized controlled trial: Crit Care, 2018; 22; 239

13.. Krumbeck JA, Rasmussen HE, Hutkins RW: Microbiome, 2018; 6; 121

14.. Cohen SA, Woodfield MC, Boyle N, Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations: Transpl Infect Dis, 2016; 18; 699-705

In Press

Case report  China

Effective Acupuncture in Treating Decade-Long Occipital Neuralgia in an Elderly Patient

Am J Case Rep In Press; DOI: 10.12659/AJCR.945546  

Case report  United Kingdom

Necrobiotic Pulmonary Nodules in Ulcerative Colitis: A Rare Case Report

Am J Case Rep In Press; DOI: 10.12659/AJCR.944005  

Case report  USA

Acute Heart Failure and Complete Heart Block in a Patient with Recurrent Diffuse Large B-Cell Lymphoma: A C...

Am J Case Rep In Press; DOI: 10.12659/AJCR.945085  

Case report  Indonesia

Successful Triple Flap Procedure for Thumb Reconstruction in Severe Hand Crush Injury

Am J Case Rep In Press; DOI: 10.12659/AJCR.945759  

Most Viewed Current Articles

21 Jun 2024 : Case report  China (mainland) 77,537

Intracranial Parasitic Fetus in a Living Infant: A Case Study with Surgical Intervention and Prognosis Anal...

DOI :10.12659/AJCR.944371

Am J Case Rep 2024; 25:e944371

0:00

07 Mar 2024 : Case report  USA 45,852

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

10 Jan 2022 : Case report  Germany 32,861

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...

DOI :10.12659/AJCR.935263

Am J Case Rep 2022; 23:e935263

23 Feb 2022 : Case report  USA 21,213

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923